Sorry, you need to enable JavaScript to visit this website.

Do human lymphocytes exposed to the fallout of the Chernobyl accident exhibit an adaptive response? 2. Challenge with bleomycin

TitoloDo human lymphocytes exposed to the fallout of the Chernobyl accident exhibit an adaptive response? 2. Challenge with bleomycin
Tipo di pubblicazioneArticolo su Rivista peer-reviewed
Anno di Pubblicazione1995
AutoriTedeschi, B., Caporossi D., Vernole P., Padovani Laura Maria, Appolloni Massimo, Anzidei Patrizia, and Mauro Francesco
RivistaMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume332
Paginazione39 - 44
Data di pubblicazione1995///
Parole chiaveAdaptive response, Bleomycin, Chernobyl, Chromosome aberration
Abstract

The present study concerns the possible adaptive response, induced in vivo by a continuous exposure to ionizing radiations, to a challenge treatment with the radiomimetic glycopeptide bleomycin (BLM). Lymphocytes from children contaminated as a consequence of Chernobyl accident were treated for the last 5 h of culture with 2.5 μg/ml BLM. The induced chromosome damage was significantly lower than that found with the same treatment in lymphocytes from control children. This hyposensitivity to BLM was still present if, 1 h after the addition of the drug, inhibitors of the enzymes involved in DNA repair, such as 3-aminobenzamide (2 mM), or aphidicolin (0.4 μM) or 3-dideoxythymidine (5 mM) were added to the cultures. The resistance to BLM in lymphocytes from contaminated children seems to be related to a mechanism upstream in respect to the activities of enzymes involved in the DNA repair and specifically linked to the action of this drug, This is consistent with the different response found when the cells were challenged with ionizing radiation in vitro, as reported in the accompanying paper (L. Padovani, L. et al. (1995) Mutation Res., this issue).

Note

Cited By (since 1996): 16Export Date: 26 August 2010Source: Scopus

URLhttp://www.scopus.com/inward/record.url?eid=2-s2.0-0028834540&partnerID=40&md5=bfecef9b68b42226b3765cf355bfdb4b
Citation Key460